Priority Date: 14.09.11 (GB 20110015906)

ESCHERICHIA COLI VACCINE COMBINATION

  • Application ID: EP12780542
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
Technology Company
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). GlaxoSmithKline and Carpmaels & Ransford LLP are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 220 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.09.2011 - Priority Date (GB 20110015906)
  • 21.03.2013 - Publication A2 (WO2013038385)
  • 23.07.2014 - Publication A2 (EP2755994)

IPC Classification